Filing Details

Accession Number:
0001127602-14-008069
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-24 19:59:10
Reporting Period:
2014-02-21
Filing Date:
2014-02-24
Accepted Time:
2014-02-24 19:59:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850693 Allergan Inc AGN Pharmaceutical Preparations (2834) 951622442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214127 Jr J Louis Lavigne 2525 Dupont Drive
Irvine CA 92612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-21 5,400 $125.79 0 No 4 S Indirect By Rachel Lavigne Exmpt Bypass Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Rachel Lavigne Exmpt Bypass Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,800 Indirect By Lavigne Survivor's Trust
Common Stock 12,723 Direct
Common Stock 0 Indirect By Lavigne Family Trust
Footnotes
  1. The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $125.77 to $125.80, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
  2. Shares held by the Rachel Lavigne Exmpt Bypass Trust. Reporting Person is sole trustee of the Rachel Lavigne Exmpt Bypass Trust.
  3. Shares held by the Louis Lavigne Survivor's Trust. Reporting Person is sole trustee of the Louis Lavigne Survivor's Trust.
  4. Shares held by the Lavigne Family Trust. Reporting Person is trustee of the Lavigne Family Trust.